drugset / Trial / NCT00643357

Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns

NCT00643357

Phase 3 Withdrawn Air Liquide
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and the safety of Kalinox® 170 bar, over a period of three consecutive care procedures in burned children. It's a international (Spain, France, Tunisia and Belgium) study with 8 investigator centers.

Timeline

Start
2008-03
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitrous Oxide Other / unclassified 50 % Inhaled
Background Oxygen Other / unclassified 50 % Inhaled

Indications

No indication recorded.